Edition:
United Kingdom

People: Kopin Corp (KOPN.OQ)

KOPN.OQ on NASDAQ Stock Exchange Global Select Market

1.22USD
22 Apr 2019
Change (% chg)

$0.03 (+2.52%)
Prev Close
$1.19
Open
$1.19
Day's High
$1.23
Day's Low
$1.18
Volume
139,070
Avg. Vol
138,136
52-wk High
$3.80
52-wk Low
$0.96

Collins, Morton 

Dr. Morton Collins, Ph.D., is Lead Independent Director of Kopin Corp., since 1985. Mr. Collins has served as one of our directors since 1985 and was elected our Lead Independent Director in 2014. Mr. Collins received his PhD in Chemical Engineering from Princeton University and his PhD in Science from University of Delaware. From October 1968 to June 1974, Mr. Collins was the Founder and Chief Executive Officer of Data Science Ventures, Inc. (DSV I). He was a Founder of DSV Associates (DSV II); DSV Partners III (DSV III); DSV Partners IV (DSV IV) and has been the Managing Partner of each since their formation in 1974, 1981 and 1985 respectively. These organizations provide venture capital and management assistance to early-stage high-technology companies. In July of 1997, Mr. Collins became a Special Limited Partner of Cardinal Partners, the successor to the DSV series of partnerships. From 2003 to 2016, Mr. Collins was a General Partner of Battelle Ventures. In January of 2017, Mr. Collins founded M Collins Ventures, a venture capital fund of which he is the Managing Partner. Mr. Collins is currently a member of the board of directors of Inovio Pharmaceuticals, Inc., a public company. During the past five years, Mr. Collins has not served on the board of directors of any other public companies or registered management investment companies other than Inovio.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Fan

1,872,100

Richard Sneider

433,538

Bor-Yeu Tsaur

473,114

Hong Choi

359,822

Paul Baker

--

David Brook

--
As Of  30 Dec 2017